Literature DB >> 31881186

μ-Opioid receptors in primary sensory neurons are involved in supraspinal opioid analgesia.

Jie Sun1, Shao-Rui Chen2, Hui-Lin Pan3.   

Abstract

Both inhibiting ascending nociceptive transmission and activating descending inhibition are involved in the opioid analgesic effect. The spinal dorsal horn is a critical site for modulating nociceptive transmission by descending pathways elicited by opioids in the brain. μ-Opioid receptors (MORs, encoded by Oprm1) are highly expressed in primary sensory neurons and their central terminals in the spinal cord. In the present study, we tested the hypothesis that MORs expressed in primary sensory neurons contribute to the descending inhibition and supraspinal analgesic effect induced by centrally administered opioids. We generated Oprm1 conditional knockout (Oprm1-cKO) mice by crossing AdvillinCre/+ mice with Oprm1flox/flox mice. Immunocytochemical labeling in Oprm1-cKO mice showed that MORs are completely ablated from primary sensory neurons and are profoundly reduced in the superficial spinal dorsal horn. Intracerebroventricular injection of morphine or fentanyl produced a potent analgesic effect in wild-type mice, but such an effect was significantly attenuated in Oprm1-cKO mice. Furthermore, the analgesic effect produced by morphine or fentanyl microinjected into the periaqueductal gray was significantly greater in wild-type mice than in Oprm1-cKO mice. Blocking MORs at the spinal cord level diminished the analgesic effect of morphine and fentanyl microinjected into the periaqueductal gray in both groups of mice. Our findings indicate that MORs expressed at primary afferent terminals in the spinal cord contribute to the supraspinal opioid analgesic effect. These presynaptic MORs in the spinal cord may serve as an interface between ascending inhibition and descending modulation that are involved in opioid analgesia.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Descending inhibition; Dorsal root ganglion; Opiate; Periaqueductal gray; Primary afferent neuron

Mesh:

Substances:

Year:  2019        PMID: 31881186      PMCID: PMC6946609          DOI: 10.1016/j.brainres.2019.146623

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  45 in total

1.  Mu- and delta-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla.

Authors:  H Wang; M W Wessendorf
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

2.  T-type channels control the opioidergic descending analgesia at the low threshold-spiking GABAergic neurons in the periaqueductal gray.

Authors:  Cheongdahm Park; Jong-Hyun Kim; Bo-Eun Yoon; Eui-Ju Choi; C Justin Lee; Hee-Sup Shin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-03       Impact factor: 11.205

3.  Opioid-induced long-term potentiation in the spinal cord is a presynaptic event.

Authors:  Hong-Yi Zhou; Shao-Rui Chen; Hong Chen; Hui-Lin Pan
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

4.  μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.

Authors:  Jie Sun; Shao-Rui Chen; Hong Chen; Hui-Lin Pan
Journal:  J Physiol       Date:  2019-01-16       Impact factor: 5.182

5.  Ability of periaqueductal gray subdivisions and adjacent loci to elicit analgesia and ability of naloxone to reverse analgesia.

Authors:  B E Thorn; L Applegate; S W Johnson
Journal:  Behav Neurosci       Date:  1989-12       Impact factor: 1.912

6.  Cloning and pharmacological characterization of a rat mu opioid receptor.

Authors:  R C Thompson; A Mansour; H Akil; S J Watson
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

Review 7.  Opioids in the brain: supraspinal mechanisms in pain control.

Authors:  T S Jensen
Journal:  Acta Anaesthesiol Scand       Date:  1997-01       Impact factor: 2.105

8.  Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.

Authors:  S-R Chen; A Prunean; H-M Pan; K L Welker; H-L Pan
Journal:  Neuroscience       Date:  2007-01-17       Impact factor: 3.590

9.  Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.

Authors:  Shao-Rui Chen; Hui-Lin Pan
Journal:  Brain Res       Date:  2006-02-24       Impact factor: 3.252

10.  Activation of mu-opioid receptors excites a population of locus coeruleus-spinal neurons through presynaptic disinhibition.

Authors:  Yu-Zhen Pan; De-Pei Li; Shao-Rui Chen; Hui-Lin Pan
Journal:  Brain Res       Date:  2004-01-30       Impact factor: 3.252

View more
  10 in total

1.  The Guts of the Opioid Crisis.

Authors:  Karan H Muchhala; Joanna C Jacob; Minho Kang; William L Dewey; Hamid I Akbarali
Journal:  Physiology (Bethesda)       Date:  2021-09-01

2.  The effect of intraoperative intrathecal opioid administration on the length of stay and postoperative pain control for patients undergoing lumbar interbody fusion.

Authors:  Alan Villavicencio; Hash Brown Taha; E Lee Nelson; Sharad Rajpal; Kara Beasley; Sigita Burneikiene
Journal:  Acta Neurochir (Wien)       Date:  2022-09-17       Impact factor: 2.816

3.  Metformin prevents morphine-induced apoptosis in rats with diabetic neuropathy: a possible mechanism for attenuating morphine tolerance.

Authors:  Onur Avci; Ercan Ozdemir; Ahmet Sevki Taskiran; Zeynep Deniz Sahin Inan; Sinan Gursoy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-02       Impact factor: 3.195

4.  Yokukansan Inhibits the Development of Morphine Tolerance by Regulating Presynaptic Proteins in DRG Neurons.

Authors:  Yusuke Ohashi; Fatma Zahra Sakhri; Hideshi Ikemoto; Takayuki Okumo; Naoki Adachi; Masataka Sunagawa
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

5.  Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.

Authors:  Karan H Muchhala; Joanna C Jacob; William L Dewey; Hamid I Akbarali
Journal:  Eur J Pharmacol       Date:  2021-03-08       Impact factor: 4.432

6.  Effects of intrathecal and intracerebroventricular microinjection of kaempferol on pain: possible mechanisms of action.

Authors:  Sajjad Jabbari; Maryam Bananej; Mohammad Zarei; Alireza Komaki; Ramin Hajikhani
Journal:  Res Pharm Sci       Date:  2021-03-05

Review 7.  Monoaminergic and Opioidergic Modulation of Brainstem Circuits: New Insights Into the Clinical Challenges of Pain Treatment?

Authors:  Isaura Tavares; José Tiago Costa-Pereira; Isabel Martins
Journal:  Front Pain Res (Lausanne)       Date:  2021-07-05

Review 8.  From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks.

Authors:  Nikolai Jaschke; Sophie Pählig; Ying-Xian Pan; Lorenz C Hofbauer; Andy Göbel; Tilman D Rachner
Journal:  Trends Endocrinol Metab       Date:  2021-03-03       Impact factor: 12.015

Review 9.  Methylene Blue Application to Lessen Pain: Its Analgesic Effect and Mechanism.

Authors:  Seung Won Lee; Hee Chul Han
Journal:  Front Neurosci       Date:  2021-05-17       Impact factor: 4.677

Review 10.  Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, via Gene-Targeted Animal Models.

Authors:  Wenjian Kang; Shan Liu; Jin Xu; Anna Abrimian; Ayma F Malik; Raymond Chien; Adejuyigbe Adaralegbe; Akwasi Amponsah; Luca Cartegni; John Pintar; Ying-Xian Pan
Journal:  Int J Mol Sci       Date:  2022-03-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.